Not a member?
Home Conditions About Therapy Community Self Assessment Resources Market Place

Alzheimer's and Dementia
» Conditions » Alzheimer's and Dementia

New Test Developed to Determine Onset of Alzheimer's

Researchers at the University of California at Los Angeles say they have created the first test that can record the onset of Alzheimer's disease. Dr. Stephen Bartels, president of the American Association of Geriatric Psychiatry, explained that the test identifies lesions associated with Alzheimer's in a person's brain and could improve early diagnosis and lead to more effective treatment. "The test," said Bartels, "is a huge step forward in getting a jump on the disease before it progresses to cause brain impairment."

ItÂ’s currently estimated that Alzheimer's, a degenerative brain disease that causes memory loss, disorientation, depression and decay of bodily functions, affects as many as 4 million Americans. The disease often begins with memory lapses and advances to dementia. People with advanced cases require constant care and lose the ability to recognize even their loved ones.

The UCLA discovery means individuals will be able to undergo a noninvasive test that includes a PET scan and the injection of a chemical tracer, which identifies the brain lesions linked to the disease. "Find these tiny lesions, and you will likely find the disease," said Dr. Jorge Barrio, who led the UCLA research team. The accuracy of current diagnostic tests can be as low as 55 percent compared with autopsy results, he added.

Positron emission tomography, or PET, uses radiation to measure biochemical reactions like those between the tracer and brain lesions, while CT and MRI scans produce anatomical images. "We think the research is very exciting, but at the same time we're cautious," said Michelle Plauche, director of health education for the Los Angeles chapter of the Alzheimer's Association. "This technology is most useful when an individual is under the care of their physician, when there's some indication this test may be useful or if the doctor is having trouble determining the cause of a patient's memory loss," she said. Plauche added that she hopes the research will prompt insurance companies to cover the $1,500 average cost of a PET scan.

The research was funded by the Department of Energy, the Charles A. Dana Foundation, the Alzheimer's Association and The Institute for the Study of Aging Inc.

Link: Find an Alzheimer's home

 

Take a test:

See also:





Related Topics

Dementia

Post Your Thoughts

Coping with Alzheimer's Disease

Related Products

Failure-Free Activities For the Alzheimer's Patient: A Guidebook For Caregivers




What You Need to Know About Alzheimer's

There's Still a Person in There: The Complete Guide to Treating and Coping With Alzheimer's


Related Links

Drug Rehab
ADHD Treatment
Rapid Detox Treatment
Senior
Assisted Living

Eating Disorder Treatment
Drug Treatment Center
Teen Drug Abuse
Bulimia Treatment
Eating Disorder Program
Drug Treatment Programs

Drug Rehab program centers

 

   

eHealthCare Awards


Affiliate Links

Sexual Addictions
Drug Addiction Treatment Center
Drug Rehab Programs
Drug Rehab Center
Heroin Detox Center
Diabetes Treatment
Cocaine Addiction Help
Drug Rehabs
Breast Cancer Treatment
Drug Rehabilitation Program


Addiction Treatment Program

Find the right Psychologist Drug Rehabilitation Center Therapist Drug Treatment Center or Drug Rehab ideally suited to your specific needs. The information provided on the 4therapy.com web site is for informational purposes only and should not be treated as medical, psychiatric, psychological or behavioral health care advice. Nothing contained on the 4therapy.com web site is intended to be used for medical diagnosis or treatment or as a substitute for consultation with a qualified health care professional. Find a qualified Psychologist in your area.

Copyright © 1998 - 2008 4therapy.com NETWORK, INC. - ALL RIGHTS RESERVED.